Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Winette T A van der Graaf

Showing results (1-10 of 401) with videos related to

Pageof 41
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|May 30, 2013
[Providing information about metastasised cancer could be better: time for a good talk]Winette T A van der Graaf
Lancet (London, England)|June 14, 2016
Olaratumab in soft-tissue sarcomasWinette T A van der Graaf
Current Treatment Options in Oncology|June 5, 2012
New systemic therapy options for advanced sarcomasWinette T A van der Graaf, Hans Gelderblom
European Journal of Cancer (Oxford, England : 1990)|August 26, 2017
The fate of new fosfamides in phase III studies in advanced soft tissue sarcomaAnastasia Constantinidou, Winette T A van der Graaf
The Lancet. Oncology|June 9, 2017
Neoadjuvant chemotherapy in localised soft-tissue sarcomas: where do we go from here?Winette T A van der Graaf, Robin L Jones
Current Opinion in Oncology|May 11, 2021
Desmoid-type fibromatosis: toward a holistic managementNicolas Penel, Bernd Kasper, Winette T A van Der Graaf
Nature Reviews. Clinical Oncology|September 30, 2009
Molecular imaging of solid tumors: exploiting the potentialWim J G Oyen, Winette T A van der Graaf
Nederlands Tijdschrift Voor Geneeskunde|December 4, 2014
[Determination of blood levels for oral anticancer drugs]Nielka P van Erp, Winette T A van der Graaf
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2021
Clinical Trials for Real-World Elderly Patients With Metastatic Soft-Tissue Sarcomas: The Importance of Study Design and Patient-Reported OutcomesEugenie Younger, Olga Husson, Winette T A van der Graaf
The Oncologist|November 7, 2008
Angiogenesis inhibition in non-GIST soft tissue sarcomasStefan Sleijfer, Winette T A van der Graaf, Jean-Yves Blay
Pageof 41

Showing results (1-10 of 401) with videos related to

Sort By:
Pageof 41
Nederlands Tijdschrift Voor Geneeskunde|May 30, 2013
[Providing information about metastasised cancer could be better: time for a good talk]Winette T A van der Graaf
Lancet (London, England)|June 14, 2016
Olaratumab in soft-tissue sarcomasWinette T A van der Graaf
Current Treatment Options in Oncology|June 5, 2012
New systemic therapy options for advanced sarcomasWinette T A van der Graaf, Hans Gelderblom
European Journal of Cancer (Oxford, England : 1990)|August 26, 2017
The fate of new fosfamides in phase III studies in advanced soft tissue sarcomaAnastasia Constantinidou, Winette T A van der Graaf
The Lancet. Oncology|June 9, 2017
Neoadjuvant chemotherapy in localised soft-tissue sarcomas: where do we go from here?Winette T A van der Graaf, Robin L Jones
Current Opinion in Oncology|May 11, 2021
Desmoid-type fibromatosis: toward a holistic managementNicolas Penel, Bernd Kasper, Winette T A van Der Graaf
Nature Reviews. Clinical Oncology|September 30, 2009
Molecular imaging of solid tumors: exploiting the potentialWim J G Oyen, Winette T A van der Graaf
Nederlands Tijdschrift Voor Geneeskunde|December 4, 2014
[Determination of blood levels for oral anticancer drugs]Nielka P van Erp, Winette T A van der Graaf
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2021
Clinical Trials for Real-World Elderly Patients With Metastatic Soft-Tissue Sarcomas: The Importance of Study Design and Patient-Reported OutcomesEugenie Younger, Olga Husson, Winette T A van der Graaf
The Oncologist|November 7, 2008
Angiogenesis inhibition in non-GIST soft tissue sarcomasStefan Sleijfer, Winette T A van der Graaf, Jean-Yves Blay
Pageof 41